Kane Biotech Inc.
KNE.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -587.00K | -514.00K | -392.30K | -441.00K | -251.90K |
| Total Depreciation and Amortization | 9.20K | 13.70K | 23.20K | 26.30K | 33.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 125.20K | 48.00K | -18.50K | 16.00K | -90.60K |
| Change in Net Operating Assets | 6.00K | 103.20K | -100.60K | -108.30K | -249.60K |
| Cash from Operations | -446.60K | -349.20K | -488.20K | -506.90K | -558.60K |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | 6.40K |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 43.60K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.70K | -9.30K | -15.70K | -4.10K | -35.90K |
| Cash from Investing | -22.70K | -9.30K | -15.70K | 39.50K | -29.50K |
| Total Debt Issued | -- | -- | -27.50K | 0.00 | 1.00M |
| Total Debt Repaid | 0.00 | -5.90K | -17.50K | -21.40K | -113.20K |
| Issuance of Common Stock | 1.13M | -- | 689.40K | 0.00 | 1.09M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -2.20K | 20.70K | -8.70K | -40.00K |
| Cash from Financing | 793.00K | -5.80K | 477.10K | -21.90K | 1.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 323.70K | -364.30K | -26.80K | -489.30K | 809.10K |